Logo for Cullinan Therapeutics Inc

Cullinan Therapeutics Investor Relations Material

Latest events

Logo for Cullinan Therapeutics Inc

Status Update

Cullinan Therapeutics
Logo for Cullinan Therapeutics

Q3 2024

7 Nov, 2024
Logo for Cullinan Therapeutics

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Cullinan Therapeutics Inc

Access all reports
Cullinan Oncology Inc, is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Leveraging a modality-agnostic approach, Cullinan Oncology is dedicated to discovering and developing medicines for high-impact oncology targets. The company's strategy involves rigorous and rapid advancement of highly differentiated molecules, resulting in a robust and diversified pipeline of oncology and immuno-oncology therapies. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.